Chemours receives violation letter from the Environmental Protection Agency


The Environmental Protection Agency has filed a notice of violation to the Chemours Co.for its sites in Fayetteville, NC and the Washington Works in West Virginia

The violations were made in connection with the Toxic Substances Control Act and cover reporting requirements for new chemicals that the EPA says are made by the company, which is based in Wilmington.

A letter outlining the violations was issued to Mark Vergnano, Chemours’ CEO.

The EPA cited six violations at Fayetteville and two at the Washington Works.

The Fayetteville site has been under fire by North Carolina environmental officials for traces of the GenX chemical found in waterways. The company’s earnings report listed a charge of more than $30 million in connection with the North Carolina site.

The federal agency said the investigation is continuing and could lead to further violation notices and demanded that the company submit a plan to correct the violations.

Chemours spokesman David Rosen issued the following statement from the company.

“Chemours is committed to taking a leadership role in environmental stewardship and supports the development of a science and risk-based approach to establish standards and guidelines for PFAS compounds. We believe collaboration and transparency are critical to achieving this.

Chemours does not use PFOA, PFOS or C8 in any of its manufacturing processes.  In fact, no Chemours plant site had ever used PFOS in its manufacturing processes, and all Chemours plant sites had ceased using PFOA at least two years before the company was established. 

Chemours has been significantly investing in emission control technologies at ourfluoroproductssites and has previously announced our global corporate responsibility goal to reduce air and water emission of fluorinated organic chemicals by 99 percent or greater. We have also collaborated with university researchers and commercial laboratories to synthesize over ten authentic reference standards and create analytical methods for PFAS byproducts, as no commercially available analytical standards or methods were available for determining concentration of these compounds. 

We are reviewing the EPA PFAS Action Plan in greater detail to determine how best we can contribute to the effort based on our significant expertise in developing analytical methods, conducting air and water sampling and identifying effective treatment technologies.”

Click here for a link to the EPA’s letter.

Facebook Comments
Previous articleChemours reports higher earnings for 2018
Posts labeled Special to Delaware Business Now are typically submitted items that are updated and sometimes rewritten in news style. Background information is sometimes added.